Company Financials

10x Genomics, Inc. Financials

United States dollar

business 10x Genomics, Inc. Company Profile

Main Stock Listing

NASDAQ: TXG

Market Capitalization $2.10 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -10.93
Forward PE -39.78
Price to Sales TTM $3.22
Price to Book MRQ $2.63
Enterprise to Revenue 2.60
Enterprise to EBITDA -17.12

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -11.89%
Operating Margin -21.17%
Return on Assets TTM -8.42%
Return on Equity TTM -10.12%

Income Statement

Revenue TTM $641,814,016
Revenue per Share TTM $5.20
Quarterly Revenue Growth -1.70%
Gross Profit TTM $442,491,008
EBITDA $-97,499,000
Net Income to Common TTM $-76,320,000
Diluted EPS TTM $-0.63
Quarterly Earnings Growth YoY -1.75%

Balance Sheet

Total Cash MRQ $482,084,000
Total Cash per Share MRQ $3.81
Total Debt MRQ $
Total Debt to Equity MRQ 11.08
Current Ratio MRQ 4.48
Book Value per Share MRQ $6.21

Cash Flow

Operating Cash Flow TTM $88,525,000
Levered Free Cash Flow TTM $112,057,624

TXG Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 126,539,546
Float Shares 114,357,133
Avg 10 Volume 1,721,230
Avg 30 Volume None
Shares Short 15,420,723
Short Ratio 5.80
Short % of Shares 19.36%
% Held by Insiders 1.82%
% Held by Institutions 108.83%

Stock Price Summary

Beta 2.15
Fifty Two Week Low $6.78
Fifty Two Week High $20.34
Fifty Two Week Change 4.21%
Day 50 MA $15.95
Day 200 MA $12.32

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date